Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.65, No.5, p.683-692, 2018 |
||
Title: Identification of critical microRNAs in gastrointestinal stromal tumor patients treated with Imatinib | ||
Author: Z. Zhang, N. y. Jiang, R. y. Guan, Y. k. Zhu, F. q. Jiang, D. Piao | ||
Abstract: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. Imatinib mesylate was considered a breakthrough drug in clinical treatment of GIST, but GIST patients showed resistance to it. We aimed to identify critical microRNAs (miRNAs) related to imatinib resistance in imatinib-treated GIST patients. Microarray datasets under accession numbers GSE63159 and GSE45901 were downloaded from the Gene Expression Omnibus (GEO) database. The differentially expressed miRNAs (DEMs) related to imatinib resistance were identified. GO function and KEGG pathway enrichment analyses were performed, and lncRNA-miRNA-target gene regulatory networks were constructed. Finally, the critical miRNAs and their target genes related to imatinib resistance or sensitivity were identified. A total of 20 DEMs in the GSE63159 dataset (7 significantly up-regulated and 13 down-regulated) and 23 DEMs in the GSE45901 dataset (8 up-regulated and 15 down-regulated) were identified. Five critical miRNAs and 109 target genes were identified in the lncRNA-miRNA-target gene regulatory networks. GO function and KEGG pathway enrichment analysis showed that DEM target genes were mainly involved in several signaling pathways, such as focal adhesion and the GnRH signaling pathway. From the five miRNAs, the overexpression of hsa-miR-28-5p and hsa-miR-125a-5p had significant correlation to imatinib resistance or imatinib sensitivity in GIST patients. In addition, Hsa-miR-28-5p and hsa-miR-125a-5p may be involved in the development and progression of GIST, and they may serve as prognostic markers for imatinib-response in GIST patients. |
||
Keywords: gastrointestinal stromal tumors; microRNAs; imatinib mesylate; RNA, long noncoding; focal adhesions; gonadotropin-releasing hormone | ||
Published online: 24-Sep-2018 | ||
Year: 2018, Volume: 65, Issue: 5 | Page From: 683, Page To: 692 | |
doi:10.4149/neo_2018_170906N575 |
||
|
download file |
|